NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
2 other identifiers
interventional
403
1 country
1
Brief Summary
The goal of this clinical trial is to test an enhanced version of the National Diabetes Prevention Program (NDPP-NextGen) that is tailored to young women in childbearing years. The investigators will recruit 360 women aged 18-39 years with overweight/obesity who are not currently pregnant, but likely to conceive within 24 months. Women will be randomized to NDPP-NextGen or a usual care control group. The NDPP-NextGen group will participate in the adapted NDPP online group class across 12 months, and the control group will get a packet of information about how to be healthy before, during and after pregnancy. The main goals of the study are:
- 1.to assess effects of NDPP-NextGen on pre-pregnancy blood sugar and early pregnancy BMI
- 2.to assess effects of NDPP-NextGen on weight gain and behavioral outcomes during pregnancy
- 3.to explore effects of NDPP-NextGen on infant's percentage of fat tissue at birth
- 4.Questionnaires about health, diet, activity, smoking, self-confidence, and depression
- 5.Body size measurements
- 6.Fasted blood draws
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 6, 2023
CompletedStudy Start
First participant enrolled
April 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
February 27, 2026
February 1, 2026
4.1 years
November 21, 2022
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BMI in early pregnancy
Height and weight will be measured and combined to report BMI at the post-conception research visit occurring at 6-8 weeks gestation.
6-8 weeks gestation
Secondary Outcomes (1)
Glycemia in early pregnancy
6-8 weeks gestation
Other Outcomes (39)
Peri-conceptional BMI
Scale data will be pulled at 6-8 weeks gestation
Rate and timing of gestational weight gain (GWG)
Scale data will be pulled weekly from time of conception up to delivery
A1C in early pregnancy
6-8 weeks gestation
- +36 more other outcomes
Study Arms (2)
Healthy Lifestyle
EXPERIMENTALWomen in the Healthy Lifestyle group will be invited to attend the online NDPP-NextGen class which will cover how to eat healthy, be active, and lose weight before getting pregnant. The classes will be led by a trained Lifestyle Coach. Each class lasts about 1 hour. Classes initially meet about once a week (for the first 6 months), then twice a month (for the next 3 months), and then once a month (for the last 3 months). Classes will meet virtually through video-conference. Lifestyle coaches will also call participants in between classes to discuss how participants are doing, answer questions, and provide reminders for upcoming classes. Prior to the first class, women will also participate in a "pre-session" designed to increase NDPP engagement via discussion of diabetes risks and treatment options (i.e., clarify relevance) and motivational interviewing to resolve barriers.
Healthy Women
NO INTERVENTIONWomen in the Healthy Women group get a packet of information standardly given in OB clinics about how to be healthy before, during and after pregnancy.
Interventions
NDPP-NextGen will incorporate content on preconception/prenatal health into standard NDPP. Participants will be encouraged to make sustainable improvements in diet and activity, but without pre-set goals to better accommodate diverse, low-income populations. Upon pregnancy, recommendations will adjust to support appropriate GWG, breastfeeding, and postpartum weight loss. We will provide education on diet and activity during pregnancy/postpartum, including sufficient energy intake and exercise safety to support the growing fetus. NDPP-NextGen will include 3 strategies to better engage young women. (1) "Pre-sessions" to increase knowledge of diabetes risks, self-efficacy, and readiness to change using motivational interviewing techniques. (2) Delivering classes remotely (via phone- and video-conference) to facilitate participation regardless of inclement weather, dependent care, illness, transportation, etc. (3) Offering classes specially for young women to increase personal relevance.
Eligibility Criteria
You may qualify if:
- Established patient at Denver Health or Atrium Health Wake Forest Baptist
- Biologically female (inclusive of all gender identities)
- Aged 18-39 years
- English- or Spanish-speaking
- BMI ≥25 kg/m2 (≥23 kg/m2 if Asian race)
- Activities that lead to pregnancy in past 3 months
- Interested in pregnancy within 24 months, including:
- High interest (actively trying to conceive)
- General interest (not actively trying but wanting to become pregnant in the foreseeable future)
- Neutral interest (not planning pregnancy or using contraception for religious reasons)
You may not qualify if:
- Currently pregnant
- Non-gestational diabetes (type 1, type 2)
- Long-acting contraceptives (intrauterine device, implant, injection) with plans to continue for \>1 year (barrier \& short-acting hormonal contraception permitted given ease of discontinuing to facilitate pregnancy)
- Medical procedures (e.g., tubal ligation, hysterectomy) or conditions that impede pregnancy
- Documented infertility or unsuccessfully trying to conceive for ≥12 months
- Prior participation in the NDPP
- History of bariatric surgery
- Use of GLP-1s in last year
- Currently receiving clinical obesity treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Sauder, PhD
Wake Forest University Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Professional research assistants who will be collecting data and conducting the research visits will not be told if participants are in the treatment or control group, although this may be disclosed by the participant.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2022
First Posted
January 6, 2023
Study Start
April 8, 2023
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2028
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share